[1]
|
Jóźwik-Plebanek, K., Saracyn, M., Kołodziej, M., Kamińska, O., Durma, A.D., Mądra, W., et al. (2024) Theranostics in Renal Cell Carcinoma—A Step Towards New Opportunities or a Dead End—A Systematic Review. Pharmaceuticals, 17, 1721. https://doi.org/10.3390/ph17121721
|
[2]
|
Padala, S.A., Barsouk, A., Thandra, K.C., Saginala, K., Mohammed, A., Vakiti, A., et al. (2020) Epidemiology of Renal Cell Carcinoma. World Journal of Oncology, 11, 79-87. https://doi.org/10.14740/wjon1279
|
[3]
|
Knežević, N., Zekulić, T., Kuliš, T., Penezić, L., Hudolin, T., Čikić, B., et al. (2023) Trends in Surgical Management of Renal Neoplasms: Single Center Results in the Last Decade. Acta Clinica Croatica, 62, 53-59.
|
[4]
|
Siemer, S., Uder, M., Zell, A., Pönicke, C., Humke, U., Ziegler, M., et al. (2001) Der bilaterale Nierentumor. Der Urologe A, 40, 114-120. https://doi.org/10.1007/s001200050448
|
[5]
|
Rothman, J., Crispen, P.L., Wong, Y., Al-Saleem, T., Fox, E. and Uzzo, R.G. (2008) Pathologic Concordance of Sporadic Synchronous Bilateral Renal Masses. Urology, 72, 138-142. https://doi.org/10.1016/j.urology.2008.01.043
|
[6]
|
Kim, J.K., Kim, H., Lee, H., Oh, J.J., Lee, S., Hong, S.K., et al. (2021) Evaluation of Functional Outcome of Bilateral Kidney Tumors after Sequential Surgery. BMC Cancer, 21, Article No. 592. https://doi.org/10.1186/s12885-021-08324-3
|
[7]
|
Deng, R., Qiu, J., Shang, J., Yu, C., Tian, P., Zhao, Z., et al. (2024) The Long-Term Survival Outcome of Sporadic Bilateral Renal Cell Carcinoma and Optimization of Surgical Treatment: A Large-Scale Population-Based Cohort Study. Clinical and Experimental Medicine, 25, Article No. 20. https://doi.org/10.1007/s10238-024-01535-5
|
[8]
|
Ohba, K., Mitsunari, K., Nakanishi, H., Yasuda, T., Nakamura, Y., Matsuo, T., et al. (2023) Initial Experience in Robot-Associated Radical Nephrectomy with Inferior Vena Cava Tumor Thrombectomy. Translational Cancer Research, 12, 3425-3431. https://doi.org/10.21037/tcr-23-862
|
[9]
|
Gu, L., Ma, X., Gao, Y., Li, H., Li, X., Chen, L., et al. (2017) Robotic versus Open Level I-II Inferior Vena Cava Thrombectomy: A Matched Group Comparative Analysis. Journal of Urology, 198, 1241-1246. https://doi.org/10.1016/j.juro.2017.06.094
|
[10]
|
Chen, J., Liu, Z., Peng, R., Liu, Y., Zhang, H., Wang, G., et al. (2024) Neoadjuvant Stereotactic Ablative Body Radiotherapy Combined with Surgical Treatment for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus: A Prospective Pilot Study. BMC Urology, 24, Article No. 31. https://doi.org/10.1186/s12894-024-01405-y
|
[11]
|
Gudapati, P. and Abouamara, M. (2022) Clear Cell Renal Cell Carcinoma with Stage IV Cavoatrial Tumour Thrombus Extension and Rapid Metastatic Reoccurrence Postsurgical Treatment with Review of Current Treatment Strategies. BMJ Case Reports, 15, e248156. https://doi.org/10.1136/bcr-2021-248156
|
[12]
|
宿佳琦, 张海梁. 局部进展期肾癌综合治疗研究进展[J]. 肿瘤防治研究, 2023, 50(6): 556-561.
|
[13]
|
Dudani, S., de Velasco, G., Wells, J.C., Gan, C.L., Donskov, F., Porta, C., et al. (2021) Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association with Survival. JAMA Network Open, 4, e2021869. https://doi.org/10.1001/jamanetworkopen.2020.21869
|
[14]
|
Ferrel, E., Roehrig, A., Kaya, E., Carlson, J., Ling, B., Wagner, A., et al. (2016) Retrospective Study of Metastatic Melanoma and Renal Cell Carcinoma to the Brain with Multivariate Analysis of Prognostic Pre-Treatment Clinical Factors. International Journal of Molecular Sciences, 17, Article 400. https://doi.org/10.3390/ijms17030400
|
[15]
|
Guillaume, Z., Auvray, M., Vano, Y., Oudard, S., Helley, D. and Mauge, L. (2022) Renal Carcinoma and Angiogenesis: Therapeutic Target and Biomarkers of Response in Current Therapies. Cancers, 14, Article 6167. https://doi.org/10.3390/cancers14246167
|
[16]
|
Jo, J.K., Seo, S.I., Kang, M., Chung, J., Kwak, C., Hong, S., et al. (2024) Optimal Sequential Therapy Using Tyrosine Kinase Inhibitors as the First-Line Treatment in Patients with Metastatic Renal Cell Carcinoma: A Nationwide Multicenter Study. Asian Journal of Urology, 11, 450-459. https://doi.org/10.1016/j.ajur.2022.11.004
|
[17]
|
Xu, W., Atkins, M.B. and McDermott, D.F. (2020) Checkpoint Inhibitor Immunotherapy in Kidney Cancer. Nature Reviews Urology, 17, 137-150. https://doi.org/10.1038/s41585-020-0282-3
|
[18]
|
Chamoto, K., Hatae, R. and Honjo, T. (2020) Current Issues and Perspectives in PD-1 Blockade Cancer Immunotherapy. International Journal of Clinical Oncology, 25, 790-800. https://doi.org/10.1007/s10147-019-01588-7
|
[19]
|
Ribas, A. and Wolchok, J.D. (2018) Cancer Immunotherapy Using Checkpoint Blockade. Science, 359, 1350-1355. https://doi.org/10.1126/science.aar4060
|
[20]
|
Meng, L., Collier, K.A., Wang, P., Li, Z., Monk, P., Mortazavi, A., et al. (2023) Emerging Immunotherapy Approaches for Advanced Clear Cell Renal Cell Carcinoma. Cells, 13, Article 34. https://doi.org/10.3390/cells13010034
|
[21]
|
晚期肾透明细胞癌系统性治疗中国专家共识专家组, 中国临床肿瘤学会肾癌专家委员会, 中国抗癌协会泌尿系统肿瘤专业委员会. 晚期肾透明细胞癌系统性治疗中国专家共识(2024版) [J]. 中华肿瘤杂志, 2024, 46(9): 844-854.
|
[22]
|
Hirose, T., Deguchi, S., Yasui, K., Inoue, M., Onoe, T., Ogawa, H., et al. (2024) The Indication of Palliative Whole-Brain Radiotherapy for Patients with Brain Metastases: A Simple Prognostic Scoring System in the Era of Stereotactic Radiosurgery. BMC Cancer, 24, Article No. 940. https://doi.org/10.1186/s12885-024-12729-1
|
[23]
|
Schiff, D., Messersmith, H., Brastianos, P.K., Brown, P.D., Burri, S., Dunn, I.F., et al. (2022) Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline. Journal of Clinical Oncology, 40, 2271-2276. https://doi.org/10.1200/jco.22.00333
|